June 3, 2015
Mace Rothenberg, Senior Vice President Clinical Development and Medical Affairs, Pfizer Oncology Mace Rothenberg, chief medical officer of Pfizer Inc.’s oncology unit, is confident that immunotherapy candidates and other pipelines along with new drugs rolled out in the past few...read more